These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1833800)

  • 1. [The regression of left ventricular hypertrophy following a short antihypertensive treatment].
    Soria F; Alegría E; Valdés M; García A; Vicente T; Apellaniz G
    Rev Esp Cardiol; 1991; 44(6):389-94. PubMed ID: 1833800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 3 hypertensive++ agents on ventricular geometry and function].
    Gómez Pajuelo C; Gómez Sánchez MA; Marín Ruiz R; Lombera Romero F; Sanz Julve M; Tascón Pérez J; Sáenz de la Calzada C
    Med Clin (Barc); 1995 Mar; 104(9):334-8. PubMed ID: 7731301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevalence of arrhythmias and repolarization changes in patients with mild or moderate essential hypertension undergoing an exercise test. Their variations with different antihypertensive treatments].
    Soria F; Alegría E; Valdés M; García A; Vicente T; Castello MJ
    An Med Interna; 1990 Nov; 7(11):565-9. PubMed ID: 2103209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
    Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
    N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special considerations in the elderly patient.
    Gerstenblith G
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():7-10. PubMed ID: 2151046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment.
    Corea L; Bentivoglio M; Verdecchia P
    Hypertension; 1983; 5(6):837-43. PubMed ID: 6228528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of left ventricular mass regression on cardiac function in hypertensive elderly individuals.
    Gerstenblith G; Schulman SP
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S25-8. PubMed ID: 2148148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
    Dunn FG; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    Circulation; 1987 Aug; 76(2):254-8. PubMed ID: 2955954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass regression in elderly hypertensives.
    Gerstenblith G
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S15-7. PubMed ID: 1289508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of left ventricular hypertrophy in patients with essential hypertension: outcome of 12 years antihypertensive treatment.
    Shigematsu S; Hiramatsu K; Aizawa T; Yamada T; Takasu N; Niwa A; Miyahara Y; Tsujino M; Shimizu Z
    Cardiology; 1990; 77(4):280-6. PubMed ID: 1981491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The echocardiographic evolution of left ventricular hypertrophy in treated hypertensive patients. A long-term follow-up].
    Román O; Oyonarte M; Lioi X; Klenner TM
    Rev Esp Cardiol; 1991 Mar; 44(3):153-60. PubMed ID: 1828606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atenolol and ramipril on regression of left ventricular hypertrophy: comparative echocardiographic assessment.
    Rosatti F; Lunardi M; Mangrella M; Filippelli A; Lampa E; Rossi F
    Adv Ther; 1995; 12(2):147-55. PubMed ID: 10150325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
    González-Juanatey JR; Amaro Cendón A; Calvo Gómez C; Vega Fernández M; García Acuña JM; Virgós Lamela A; Gil de la Peña M
    Med Clin (Barc); 1992 Mar; 98(11):401-4. PubMed ID: 1533259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.